Proteomics for monitoring immune responses to cancer vaccines

Current Opinion in Molecular Therapeutics

Volumn 5, Issue 1, 2003, Pages 39-43

  Mosca, Paul J ^a   Lyerly, H Kim ^a   Ching, C Denise ^a   Hobeika, Amy C ^a   Clay, Timothy M ^a   Morse, Michael A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cancer vaccine; Cytokine; Immunity; Immunoproteomics; Mass spectrometry; Protein microarray; T cell

Indexed keywords

BIOLOGICAL MARKER; CANCER VACCINE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

ANTIGEN SPECIFICITY; CANCER IMMUNOTHERAPY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL PROCEDURES; IMMUNOSURVEILLANCE; LABORATORY AUTOMATION; LIQUID CHROMATOGRAPHY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CONTENT; PROTEOMICS; QUANTITATIVE ASSAY; REGULATORY MECHANISM; REVIEW; SENSITIVITY ANALYSIS; SIGNAL NOISE RATIO; T LYMPHOCYTE; TANDEM MASS SPECTROMETRY; TUMOR IMMUNITY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; ANTIBODIES, NEOPLASM; CANCER VACCINES; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; MONITORING, IMMUNOLOGIC; PROTEOMICS; T-LYMPHOCYTES;

EID: 0037300804     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Keilholz U, Weber J, Finke JH, Gabrilovich DI, Kast WM, Disis ML, Kirkwood JM, Scheibenbogen C, Schlom J, Maino VC, Lyerty HK et al: Immunological monitoring of cancer vaccine therapy: Results of a workshop sponsored by the Society for Biological Therapy. J Immunother (2002) 25(2):97-138.
2. Morse MA, Clay TM, Hobeika AC, Mosca PJ, Lyerly HK: Monitoring cellular immune responses to cancer immunotherapy. Curr Opin Mol Ther (2001) 3(1):45-52.
3. McCutcheon M, Wehner N, Wensky A, Kushner M, Doan S, Hsiao L, Calabresi P, Ha T, Tran TV, Tate KM, Winkelhake J et al: A sensitive ELISpot assay to detect low-frequency human T-lymphocytes. J Immunol Methods (1997) 210(2):149-166.
4. Asai T, Storkus WJ, Whiteside TL: Evaluation of the modified ELISPOT assay for interferon-γ production in cancer patients receiving antitumor vaccines. Clin Diagn Lab Immunol (2000) 7(2):145-154.
5. Carson RT, Vignali DA: Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Methods (1999) 227(1-2):41-52.
6. Kellar KL, Kalwar RR, Dubois KA, Crouse D, Chafin WD, Kane BE: Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry (2001) 45(1):27-36.
7. Kruse N, Pette M, Toyka K, Rieckmann P: Quantification of cytokine mRNA expression by RT-PCR in samples of previously frozen blood. J Immunol Methods (1997) 210(2):195-203.
8. Liebler DC: Introduction to Proteomics: Tools for the New Biology. Humana Press, Totowa, NJ, USA (2002) 3:23-24, 185-193.
9. Meri S, Baumann M: Proteomics: Post-translational modifications, immune responses and current analytical tools. Biomol Eng (2001) 18(5):213-220.
10. Liotta LA, Kohn EC, Petricoin EF: Clinical proteomics: Personalized molecular medicine. J Am Med Assoc (2001) 286(18):2211-2214.
11. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA: Use of proteomic patterns in serum to identify ovarian cancer. Lancet (2002) 359(9306):572-577.
12. Simone NL, Remaley AT, Charboneau L, Petricoin EF 3rd, Glickman JW, Emmert-Buck MR, Fleisher TA, Liotta LA: Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection. Am J Pathol (2000) 156(2):445-452.
13. Emmert-Buck MR, Gillespie JW, Paweletz CP, Ornstein DK, Basrur V, Appella E, Wang QH, Huang J, Hu N, Taylor P, Petricoin EF 3rd: An approach to proteomic analysis of human tumors. Mol Carcinog (2000) 27(3):158-165.
14. Cox AL, Skipper J, Chen Y, Henderson RA, Darrow TL, Shabanowitz J, Engelhard VH, Hunt DF, Slingluff CL Jr: Identification of a peptide recognized by five melanoma-specific human cytotoxic T-cell lines. Science (1994) 264(5159):716-719.
15. Hoffmann KF, McCarty TC, Segal DH, Chiaramonte M, Hesse M, Davis EM, Cheever AW, Meltzer PS, Morse HC 3rd, Wynn TA: Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type 1 and type 2 cytokine-madiated inflammatory reactions. FASEB J (2001) 15(13):2545-2547.
16. Rus V, Atamas SP, Shustova V, Luzina IG, Selaru F, Magder LS, Via CS: Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin Immunol (2002) 102(3):283-290.
17. Huang RP: Detection of multiple proteins in an antibody-based protein microarray system. J Immunol Methods (2001) 255(1-2):1-13.
18. Tam SW, Wiese R, Lee S, Gilmore J, Kumble KD: Simultaneous analysis of eight human Th1/Th2 cytokines using microarrays. J Immunol Methods (2002) 261(1-2):157-165.
19. Schweitzer B, Roberts S, Grimwade B, Shao W, Wang M, Fu Q, Shu Q, Laroche I, Zhou Z, Tchernev VT, Christiansen J et al: Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat Biotechnol (2002) 20(4):359-365.
20. Lopez-Otin C, Overall CM: Protease degradomics: A new challenge for proteomics. Nat Rev Mol Cell Biol (2002) 3(7):509-519.
21. Ekstrom S, Ericsson D, Onnerfjord P, Bengtsson M, Nilsson J, Marko-Varga G, Laurell T: Signal amplification using "spot-on-a-chip" technology for the identification of proteins via MALDI-TOF MS. Anal Chem (2001) 73(2):214-219.
22. Hurst GB, Buchanan MV, Foote LJ, Kennel SJ: Analysis for TNF-α using solid-phase affinity capture with radiolabel and MALDI-MS detection. Anal Chem (1999) 71(20):4727-4733.
23. Griffin TJ, Gygi SP, Rist B, Aebersold R, Loboda A, Jilkine A, Ens W, Standing KG: Quantitative proteomic analysis using a MALDI quadrupole time-of-flight mass spectrometer. Anal Chem (2001) 73(5):978-986.
24. Nyman TA, Rosengren A, Syyrakki S, Pellinen TP, Rautajoki K, Lahesmaa R: A proteome database of human primary T-helper cells. Electrophoresis (2001) 22(20):4375-4382.